PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Aciclovir
Presentation Product Chemical substance Chapter Items dispensed
Aviral 5% cream
1310030C0BIAAAA
Aviral Aciclovir Skin No data available
Clearsore 5% cream
1310030C0BHAAAA
Clearsore Aciclovir Skin No data available
Duvimex 800mg dispersible tablets
0503021C0BDAAAE
Duvimex Aciclovir Infections No data available
Galpharm Cold Sore 5% cream
1310030C0BJAAAA
Galpharm (Aciclovir) Aciclovir Skin No data available
Lloydspharmacy Cold Sore 5% cream
1310030C0BMAAAA
Lloydspharmacy (Aciclovir) Aciclovir Skin No data available
Lypsyl Cold Sore 5% cream
1310030C0BLAAAA
Lypsyl Aciclovir Skin No data available
Numark Cold Sore 5% cream
1310030C0BQAAAA
Numark (Aciclovir) Aciclovir Skin No data available
Pinewood Cold Sore 5% cream
1310030C0BPAAAA
Pinewood (Aciclovir) Aciclovir Skin No data available
Ranovir 200mg tablets
0503021C0BEAAAB
Ranovir Aciclovir Infections No data available
Soothelip 5% cream
1310030C0BDAAAA
Soothelip Aciclovir Skin No data available
Soraway Cold Sore 5% cream
1310030C0BKAAAA
Soraway Aciclovir Skin No data available
Viralief 5% cream
1310030C0BGAAAA
Viralief Aciclovir Skin No data available
Virovir 200mg tablets
0503021C0BCAAAB
Virovir Aciclovir Infections No data available
Virovir 400mg tablets
0503021C0BCABAC
Virovir Aciclovir Infections No data available
Virovir 800mg tablets
0503021C0BCACAD
Virovir Aciclovir Infections No data available
Zovirax 400mg dispersible tablets
0503021C0BBAHAH
Zovirax (Systemic) Aciclovir Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.